Category:Pages using DynamicPageList parser function
From BugSigDB
Pages in category "Pages using DynamicPageList parser function"
The following 200 pages are in this category, out of 5,435 total.
(previous page) (next page)S
- The gut microbiota in conventional and serrated precursors of colorectal cancer
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1/Signature 2
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 2
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 2/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 2/Signature 2
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 3
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 3/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 4
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 4/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 4/Signature 2
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 5
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 5/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 6
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 6/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 7
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 7/Signature 1
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 7/Signature 2
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1/Signature 1
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1/Signature 2
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 2
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 2/Signature 1
- Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 2/Signature 2
- Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
- Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1
- Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1/Signature 1
- Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1/Signature 2
- Gut microbiome alterations in patients with stage 4 hepatitis C
- Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1
- Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1/Signature 1
- Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1/Signature 2
- The lung microbiome in moderate and severe chronic obstructive pulmonary disease
- The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1
- The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1/Signature 1
- The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1/Signature 2
- The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 2
- The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 2/Signature 1
- Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
- Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease/Experiment 1
- Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease/Experiment 1/Signature 1
- Pyrosequencing study of fecal microflora of autistic and control children
- Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1
- Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1/Signature 1
- Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1/Signature 2
- Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults
- Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1
- Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1/Signature 1
- Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1/Signature 2
- A comprehensive analysis of breast cancer microbiota and host gene expression
- A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1
- A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1/Signature 1
- A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1/Signature 2
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 2
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 2/Signature 1
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 1
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 1/Signature 1
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 2
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 2/Signature 1
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 3
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 3/Signature 1
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 4
- Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 4/Signature 1
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1/Signature 1
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1/Signature 2
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 2
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 2/Signature 1
- The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 2/Signature 2
- The tongue microbiome in healthy subjects and patients with intra-oral halitosis
- The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1
- The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1/Signature 1
- The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1/Signature 2
- The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study
- The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1
- The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1/Signature 1
- The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1/Signature 2
- Melatonin prevents obesity through modulation of gut microbiota in mice
- Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1
- Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1/Signature 1
- Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1/Signature 2
- Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 2
- Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 2/Signature 1
- Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 2/Signature 2
- Altered gut microbiota profile in patients with generalized anxiety disorder
- Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1
- Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1/Signature 1
- Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1/Signature 2
- Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2
- Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2/Signature 1
- Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2/Signature 2
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1/Signature 1
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1/Signature 2
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 2
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 2/Signature 1
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 2/Signature 2
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3/Signature 1
- High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 3/Signature 2
- Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study
- Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1
- Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1/Signature 1
- Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1/Signature 2
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1/Signature 1
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1/Signature 2
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 2
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 2/Signature 1
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 2/Signature 2
- 16S gut community of the Cameron County Hispanic Cohort
- 16S gut community of the Cameron County Hispanic Cohort/Experiment 1
- 16S gut community of the Cameron County Hispanic Cohort/Experiment 1/Signature 1
- 16S gut community of the Cameron County Hispanic Cohort/Experiment 1/Signature 2
- Analysis of Gut Microbiota in Patients with Parkinson's Disease
- Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1
- Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1/Signature 1
- Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1/Signature 2
- Gut microbiome alterations in Alzheimer's disease
- Gut microbiome alterations in Alzheimer's disease/Experiment 1
- Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 1
- Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 2
- Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function
- Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1
- Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1/Signature 1
- Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1/Signature 2
- Microbiome dynamics of human epidermis following skin barrier disruption
- Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1
- Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1/Signature 1
- Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1/Signature 2
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1/Signature 1
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1/Signature 2
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 2
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 2/Signature 1
- Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 2/Signature 2
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1/Signature 1
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1/Signature 2
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 2
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 2/Signature 1
- Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 2/Signature 2
- Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
- Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
- Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 1
- Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 2
- Altered fecal microbiota composition in patients with major depressive disorder
- Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1
- Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1/Signature 1
- Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1/Signature 2
- Altered fecal microbiota composition in patients with major depressive disorder/Experiment 2
- Altered fecal microbiota composition in patients with major depressive disorder/Experiment 2/Signature 1
- Altered fecal microbiota composition in patients with major depressive disorder/Experiment 2/Signature 2
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1/Signature 1
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1/Signature 2
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2/Signature 1
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2/Signature 2
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3/Signature 1
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3/Signature 2
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 1
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1/Signature 2
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2/Signature 1
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 2/Signature 2
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3/Signature 1
- Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 3/Signature 2
- Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests
- Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1
- Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1/Signature 1
- Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1/Signature 2
- Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing
- Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1
- Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1/Signature 1
- Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1/Signature 2
- A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode
- A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 1
- A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 1/Signature 1
